Retention, Burden and the Participant Who Wants to Stop

Part of Principal Investigator (PI) Training: Recruitment, Enrollment and Retention.

About 4 minutes. Free, in your language, no account needed.

Why this matters

Retention is where the trial's interests and the participant's interests are closest to being genuinely opposed, and where the language of clinical research is least helpful. Sites talk about "retention strategies" and "loss to follow-up" as though the problem were leakage from a container.

The person is not leaking. They have had enough, or something in their life changed, or the study is harder than anyone told them it would be.

Two different problems that look the same

Burden you can fix. Visits that clash with work, travel that costs money, a schedule nobody walked them through, an eight-hour day they did not expect. Section 2.9.2 asks for a reasonable effort to ascertain and address the reasons for premature withdrawal — and address is the operative word. Solving a transport problem is not persuasion; it is removing an obstacle that was never part of the bargain.

A decision you must respect. They no longer want to take part. Section 2.8.3 is unambiguous: participation is voluntary and a participant may withdraw at any time without penalty or loss of benefits to which they are otherwise entitled. There is no version of retention that survives contact with that sentence.

The skill is telling the two apart, and the way to do it is to ask once, openly, and then believe the answer.

The signals that come before the words

Most participants do not announce it. They become hard to schedule. Look for the pattern, because catching it early is when the fixable version is still fixable:

Any of these is a reason for a short, direct conversation. Not a retention call from the coordinator — a conversation with their doctor about whether this is still right for them.

What legitimate retention looks like

Everything on this list makes participation easier without making leaving harder:

And what it never looks like: making them feel they are letting you down, implying their care changes, delaying an answer until "after the next visit", or having someone more senior call to persuade them.

When they do stop

Module 6 covered the mechanics — the three distinct acts of stopping product, leaving the trial, and withdrawing permission to use data already collected (§2.9.1). Two things bear repeating here.

Ask separately about safety follow-up. Many people who will not attend another study visit will happily accept a phone call. An untracked participant with an unresolved trial-related event is the worst outcome available, and §2.7.1(c) does not stop applying because someone withdrew.

Say the last sentence. "Thank you, this was your decision to make, and your care here does not change." It costs nothing, it is true, and it is the sentence that determines whether they, or anyone they talk to, ever consider a trial again.

Key takeaways